Shares of Fluidigm Corp. (NASDAQ:FLDM) saw unusually-high trading volume on Monday . Approximately 114,835 shares traded hands during mid-day trading, a decline of 7% from the previous session’s volume of 123,319 shares.The stock last traded at $9.63 and had previously closed at $9.69.

A number of research analysts have recently commented on the company. Zacks Investment Research upgraded Fluidigm Corp. from a “hold” rating to a “buy” rating and set a $10.00 target price for the company in a research note on Tuesday, July 5th. Cantor Fitzgerald restated a “buy” rating and issued a $13.00 target price on shares of Fluidigm Corp. in a research note on Thursday, June 2nd. Deutsche Bank AG assumed coverage on Fluidigm Corp. in a research note on Wednesday, June 1st. They issued a “buy” rating for the company. Mizuho lowered their target price on Fluidigm Corp. from $11.00 to $8.00 and set a “buy” rating for the company in a research note on Thursday, May 5th. Finally, Leerink Swann lowered their target price on Fluidigm Corp. from $20.00 to $15.00 and set an “outperform” rating for the company in a research note on Tuesday, April 12th. Five equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $13.74.

The firm’s market capitalization is $278.57 million. The firm has a 50-day moving average of $9.77 and a 200-day moving average of $8.43.

Fluidigm Corp. (NASDAQ:FLDM) last released its earnings results on Thursday, May 5th. The company reported ($0.40) EPS for the quarter, beating analysts’ consensus estimates of ($0.53) by $0.13. The business had revenue of $29 million for the quarter, compared to the consensus estimate of $26.95 million. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.25) EPS. On average, equities analysts expect that Fluidigm Corp. will post ($2.24) EPS for the current fiscal year.

Several hedge funds and institutional investors have added to or reduced their stakes in FLDM. Marshall Wace LLP purchased a new position in shares of Fluidigm Corp. during the fourth quarter valued at about $1,045,000. Neuberger Berman Group LLC boosted its position in shares of Fluidigm Corp. by 38.1% in the fourth quarter. Neuberger Berman Group LLC now owns 572,319 shares of the company’s stock valued at $6,187,000 after buying an additional 157,760 shares during the period. Finally, Columbia Wanger Asset Management LLC purchased a new position in shares of Fluidigm Corp. during the fourth quarter valued at about $19,337,000.

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.